Ascending Multiple-Doses of Erenumab (AMG 334) in Healthy Adults and in Migraine Patients
Clinical trial NCT01723514 · COMPLETED
Trial details
- NCT number
- NCT01723514
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-14
- Primary completion
- 2014-07-10
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.